Patterns and predictors of physician adoption of new cardiovascular drugs.

about

Patterns and predictors of physician adoption of new cardiovascular drugs.

Item

http://www.wikidata.org/entity/Q46590970

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Patterns and predictors of physician adoption of new cardiovascular drugs.

@en

Patterns and predictors of physician adoption of new cardiovascular drugs.

@nl

type

Item

label

Patterns and predictors of physician adoption of new cardiovascular drugs.

@en

Patterns and predictors of physician adoption of new cardiovascular drugs.

@nl

prefLabel

Patterns and predictors of physician adoption of new cardiovascular drugs.

@en

Patterns and predictors of physician adoption of new cardiovascular drugs.

@nl

P1476

Patterns and predictors of physician adoption of new cardiovascular drugs.

@en

P2093

Bobby Jones

http://www.w3.org/2001/XMLSchema#string

Chung-Chou H Chang

http://www.w3.org/2001/XMLSchema#string

Haiden A Huskamp

http://www.w3.org/2001/XMLSchema#string

Hasan Guclu

http://www.w3.org/2001/XMLSchema#string

Julie M Donohue

http://www.w3.org/2001/XMLSchema#string

Niteesh K Choudhry

http://www.w3.org/2001/XMLSchema#string

Rouxin Zhang

http://www.w3.org/2001/XMLSchema#string

Seth Richards-Shubik

http://www.w3.org/2001/XMLSchema#string

Timothy S Anderson

http://www.w3.org/2001/XMLSchema#string

Walid F Gellad

http://www.w3.org/2001/XMLSchema#string

P2860

Direct thrombin inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in people with non-valvular atrial fibrillation

Factors affecting the uptake of new medicines: a systematic literature review

Pharmaceutical Industry–Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report

National study of physician awareness and adherence to cardiovascular disease prevention guidelines

Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients

Enhancing prescription drug innovation and adoption

Availability of comparative efficacy data at the time of drug approval in the United States.

Updated report on comparative effectiveness of ACE inhibitors, ARBs, and direct renin inhibitors for patients with essential hypertension: much more data, little new information.

Patterns of medication initiation in newly diagnosed diabetes mellitus: quality and cost implications

P31

scholarly article

P356

10.1016/J.HJDSI.2017.09.004

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29066168

http://www.w3.org/2001/XMLSchema#string

P932

5910251

http://www.w3.org/2001/XMLSchema#string